
Vektor Medical provides a non-invasive AI tool that maps cardiac arrhythmias from standard 12‑lead ECGs to help physicians locate arrhythmia sources and guide treatment. The company’s FDA-cleared and CE-marked vMap product uses machine learning models and signal-processing algorithms (implemented with AI/ML technologies and Python) to generate beat-by-beat 2D and 3D maps across all four heart chambers. vMap is delivered as a SaaS clinical workflow tool for electrophysiologists and hospitals and integrates into procedural workflows used during cardiac ablation planning and guidance. Clinical studies reported reductions in procedure duration, time to ablation, and fluoroscopy usage alongside improved patient outcomes. Vektor targets the cardiac electrophysiology market by enabling faster, more targeted ablation and greater procedural efficiency.

Vektor Medical provides a non-invasive AI tool that maps cardiac arrhythmias from standard 12‑lead ECGs to help physicians locate arrhythmia sources and guide treatment. The company’s FDA-cleared and CE-marked vMap product uses machine learning models and signal-processing algorithms (implemented with AI/ML technologies and Python) to generate beat-by-beat 2D and 3D maps across all four heart chambers. vMap is delivered as a SaaS clinical workflow tool for electrophysiologists and hospitals and integrates into procedural workflows used during cardiac ablation planning and guidance. Clinical studies reported reductions in procedure duration, time to ablation, and fluoroscopy usage alongside improved patient outcomes. Vektor targets the cardiac electrophysiology market by enabling faster, more targeted ablation and greater procedural efficiency.
Product: vMap — FDA-cleared, CE-marked AI-based, non-invasive 12-lead ECG arrhythmia mapping (2D/3D, four chambers)
Use case: Triage, procedural planning, and guidance for cardiac ablation
Founded: 2017
Headquarters: San Diego, California
Recent financing: Series A led/co-led by Solas BioVentures and TVM Capital Life Science
| Company |
|---|
Cardiac electrophysiology — non-invasive arrhythmia mapping and ablation guidance
2017
Medical Equipment Manufacturing
16,000,000 USD
Announced Feb 5, 2024; closed Mar 6, 2025 (closing date reported)
“Solas BioVentures; TVM Capital Life Science”
Director of Finance / Controller
Location: San Diego, CA (Hybrid)
Industry: Medical Technology
Reports to: CFO
About the Role
We are seeking a Director-level Controller to lead our accounting and financial reporting functions as we scale. This role will be a key partner to executive leadership, ensuring financial integrity, operational excellence, and compliance in a highly regulated environment.
The ideal candidate brings deep technical accounting expertise, hands-on leadership, and experience supporting growth-stage companies in medtech, life sciences, or similarly regulated industries. This role ensures compliance with US GAAP, supports R&D-driven financial planning, and builds scalable accounting processes to support growth, clinical development, and potential IPO or M&A activity.
Key Responsibilities
Financial Leadership & Close
Technical Accounting & Compliance
Operational & Strategic Finance
Team & Systems Leadership
Qualifications
Required
Preferred
Key Competencies